Rituximab for Adults With Multi-Drug Resistant Focal Segmental Glomerulosclerosis: A Case Series and Review of the Literature

BACKGROUND: Adults with primary focal segmental glomerulosclerosis (FSGS) are frequently resistant to multiple immunosuppressive agents, which is associated with ongoing complications of nephrotic syndrome and a high risk of progression to end-stage renal disease (ESRD). Rituximab, a monoclonal anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ellia, Ghadiri, Siavash, Pai, Alexander, Marin, Judith G., Barbour, Sean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Clinical Research Quantitative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021507/
https://www.ncbi.nlm.nih.gov/pubmed/35465258
http://dx.doi.org/10.1177/20543581221090010

Ejemplares similares

Ejemplares similares